Peripheral Intervention Drug-Eluting Devices Market - Forecast(2024 - 2030)
1. Peripheral Intervention Drug-Eluting Devices Market - Overview
1.1 Definitions and Scope
2. Peripheral Intervention Drug-Eluting Devices Market - Executive summary
2.1 Market Revenue, Market Size and Key Trends by Company
2.2 Key Trends by type of Application
2.3 Key Trends segmented by Geography
3. Peripheral Intervention Drug-Eluting Devices Market
3.1 Comparative analysis
3.1.1 Product Benchmarking - Top 10 companies
3.1.2 Top 5 Financials Analysis
3.1.3 Market Value split by Top 10 companies
3.1.4 Patent Analysis - Top 10 companies
3.1.5 Pricing Analysis
4. Peripheral Intervention Drug-Eluting Devices Market - Startup companies Scenario Premium
4.1 Top 10 startup company Analysis by
4.1.1 Investment
4.1.2 Revenue
4.1.3 Market Shares
4.1.4 Market Size and Application Analysis
4.1.5 Venture Capital and Funding Scenario
5. Peripheral Intervention Drug-Eluting Devices Market - Industry Market Entry Scenario Premium
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis - Top 10 companies
6. Peripheral Intervention Drug-Eluting Devices Market Forces
6.1 Drivers
6.2 Constraints
6.3 Challenges
6.4 Porters five force model
6.4.1 Bargaining power of suppliers
6.4.2 Bargaining powers of customers
6.4.3 Threat of new entrants
6.4.4 Rivalry among existing players
6.4.5 Threat of substitutes
7. Peripheral Intervention Drug-Eluting Devices Market -Strategic analysis
7.1 Value chain analysis
7.2 Opportunities analysis
7.3 Product life cycle
7.4 Suppliers and distributors Market Share
8. Peripheral Intervention Drug-Eluting Devices Market - By Type (Market Size -$Million / $Billion)
8.1 Market Size and Market Share Analysis
8.2 Application Revenue and Trend Research
8.3 Segment Analysis
8.3.1 Drug-Eluting Balloon
8.3.2 Drug-Eluting Stent
9. Peripheral Intervention Drug-Eluting Devices Market - By Procedure (Market Size -$Million / $Billion)
9.1 Plain Old Balloon Angioplasty
9.2 Percutaneous Transluminal Angioplasty
10. Peripheral Intervention Drug-Eluting Devices - By Application (Market Size -$Million / $Billion)
11. Peripheral Intervention Drug-Eluting Devices- By Geography (Market Size -$Million / $Billion)
11.1 Peripheral Intervention Drug-Eluting Devices Market - North America Segment Research
11.2 North America Market Research (Million / $Billion)
11.2.1 Segment type Size and Market Size Analysis
11.2.2 Revenue and Trends
11.2.3 Application Revenue and Trends by type of Application
11.2.4 Company Revenue and Product Analysis
11.2.5 North America Product type and Application Market Size
11.2.5.1 U.S
11.2.5.2 Canada
11.2.5.3 Mexico
11.2.5.4 Rest of North America
11.3 Peripheral Intervention Drug-Eluting Devices- South America Segment Research
11.4 South America Market Research (Market Size -$Million / $Billion)
11.4.1 Segment type Size and Market Size Analysis
11.4.2 Revenue and Trends
11.4.3 Application Revenue and Trends by type of Application
11.4.4 Company Revenue and Product Analysis
11.4.5 South America Product type and Application Market Size
11.4.5.1 Brazil
11.4.5.2 Venezuela
11.4.5.3 Argentina
11.4.5.4 Ecuador
11.4.5.5 Peru
11.4.5.6 Colombia
11.4.5.7 Costa Rica
11.4.5.8 Rest of South America
11.5 Peripheral Intervention Drug-Eluting Devices- Europe Segment Research
11.6 Europe Market Research (Market Size -$Million / $Billion)
11.6.1 Segment type Size and Market Size Analysis
11.6.2 Revenue and Trends
11.6.3 Application Revenue and Trends by type of Application
11.6.4 Company Revenue and Product Analysis
11.6.5 Europe Segment Product type and Application Market Size
11.6.5.1 U.K
11.6.5.2 Germany
11.6.5.3 Italy
11.6.5.4 France
11.6.5.5 Netherlands
11.6.5.6 Belgium
11.6.5.7 Denmark
11.6.5.8 Spain
11.6.5.9 Rest of Europe
11.7 Peripheral Intervention Drug-Eluting Devices - APAC Segment Research
11.8 APAC Market Research (Market Size -$Million / $Billion)
11.8.1 Segment type Size and Market Size Analysis
11.8.2 Revenue and Trends
11.8.3 Application Revenue and Trends by type of Application
11.8.4 Company Revenue and Product Analysis
11.8.5 APAC Segment - Product type and Application Market Size
11.8.5.1 China
11.8.5.2 Australia
11.8.5.3 Japan
11.8.5.4 South Korea
11.8.5.5 India
11.8.5.6 Taiwan
11.8.5.7 Malaysia
11.8.5.8 Hong kong
11.8.5.9 Rest of APAC
11.9 Peripheral Intervention Drug-Eluting Devices - Middle East Segment and Africa Segment Research
11.10 Middle East & Africa Market Research (Market Size -$Million / $Billion)
11.10.1 Segment type Size and Market Size Analysis
11.10.2 Revenue and Trend Analysis
11.10.3 Application Revenue and Trends by type of Application
11.10.4 Company Revenue and Product Analysis
11.10.5 Middle East Segment Product type and Application Market Size
11.10.5.1 Israel
11.10.5.2 Saudi Arabia
11.10.5.3 UAE
11.10.6 Africa Segment Analysis
11.10.6.1 South Africa
11.10.6.2 Rest of Middle East & Africa
12. Peripheral Intervention Drug-Eluting Devices Market - Entropy
12.1 New product launches
12.2 M&A s, collaborations, JVs and partnerships
13. Peripheral Intervention Drug-Eluting Devices Market - Industry / Segment Competition landscape Premium
13.1 Market Share Analysis
13.1.1 Market Share by Country- Top companies
13.1.2 Market Share by Region- Top 10 companies
13.1.3 Market Share by type of Application - Top 10 companies
13.1.4 Market Share by type of Product / Product category- Top 10 companies
13.1.5 Market Share at global level - Top 10 companies
13.1.6 Best Practises for companies
14. Peripheral Intervention Drug-Eluting Devices Market - Key Company List by Country Premium
15. Peripheral Intervention Drug-Eluting Devices Market Company Analysis
15.1 Market Share, Company Revenue, Products, M&A, Developments
15.2 Abbott Laboratory
15.3 B. Braun Melsungen Ag
15.4 Biosensors International Group Ltd
15.5 Boston Scientific Corporation
15.6 C R Bard, Inc
15.7 Cardinal Health
15.8 Medtronic Plc
15.9 St Jude Medical, Inc
15.10 Terumo Corporation
15.11 The Lubrizol Corporation
15.12 Company 11
15.13 Company 12 & More
16.1 Abbreviations
16.2 Sources
17. Peripheral Intervention Drug-Eluting Devices Market - Methodology
17.1 Research Methodology
17.1.1 Company Expert Interviews
17.1.2 Industry Databases
17.1.3 Associations
17.1.4 Company News
17.1.5 Company Annual Reports
17.1.6 Application Trends
17.1.7 New Products and Product database
17.1.8 Company Transcripts
17.1.9 R&D Trends
17.1.10 Key Opinion Leaders Interviews
17.1.11 Supply and Demand Trends
1.1 Definitions and Scope
2. Peripheral Intervention Drug-Eluting Devices Market - Executive summary
2.1 Market Revenue, Market Size and Key Trends by Company
2.2 Key Trends by type of Application
2.3 Key Trends segmented by Geography
3. Peripheral Intervention Drug-Eluting Devices Market
3.1 Comparative analysis
3.1.1 Product Benchmarking - Top 10 companies
3.1.2 Top 5 Financials Analysis
3.1.3 Market Value split by Top 10 companies
3.1.4 Patent Analysis - Top 10 companies
3.1.5 Pricing Analysis
4. Peripheral Intervention Drug-Eluting Devices Market - Startup companies Scenario Premium
4.1 Top 10 startup company Analysis by
4.1.1 Investment
4.1.2 Revenue
4.1.3 Market Shares
4.1.4 Market Size and Application Analysis
4.1.5 Venture Capital and Funding Scenario
5. Peripheral Intervention Drug-Eluting Devices Market - Industry Market Entry Scenario Premium
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis - Top 10 companies
6. Peripheral Intervention Drug-Eluting Devices Market Forces
6.1 Drivers
6.2 Constraints
6.3 Challenges
6.4 Porters five force model
6.4.1 Bargaining power of suppliers
6.4.2 Bargaining powers of customers
6.4.3 Threat of new entrants
6.4.4 Rivalry among existing players
6.4.5 Threat of substitutes
7. Peripheral Intervention Drug-Eluting Devices Market -Strategic analysis
7.1 Value chain analysis
7.2 Opportunities analysis
7.3 Product life cycle
7.4 Suppliers and distributors Market Share
8. Peripheral Intervention Drug-Eluting Devices Market - By Type (Market Size -$Million / $Billion)
8.1 Market Size and Market Share Analysis
8.2 Application Revenue and Trend Research
8.3 Segment Analysis
8.3.1 Drug-Eluting Balloon
8.3.2 Drug-Eluting Stent
9. Peripheral Intervention Drug-Eluting Devices Market - By Procedure (Market Size -$Million / $Billion)
9.1 Plain Old Balloon Angioplasty
9.2 Percutaneous Transluminal Angioplasty
10. Peripheral Intervention Drug-Eluting Devices - By Application (Market Size -$Million / $Billion)
11. Peripheral Intervention Drug-Eluting Devices- By Geography (Market Size -$Million / $Billion)
11.1 Peripheral Intervention Drug-Eluting Devices Market - North America Segment Research
11.2 North America Market Research (Million / $Billion)
11.2.1 Segment type Size and Market Size Analysis
11.2.2 Revenue and Trends
11.2.3 Application Revenue and Trends by type of Application
11.2.4 Company Revenue and Product Analysis
11.2.5 North America Product type and Application Market Size
11.2.5.1 U.S
11.2.5.2 Canada
11.2.5.3 Mexico
11.2.5.4 Rest of North America
11.3 Peripheral Intervention Drug-Eluting Devices- South America Segment Research
11.4 South America Market Research (Market Size -$Million / $Billion)
11.4.1 Segment type Size and Market Size Analysis
11.4.2 Revenue and Trends
11.4.3 Application Revenue and Trends by type of Application
11.4.4 Company Revenue and Product Analysis
11.4.5 South America Product type and Application Market Size
11.4.5.1 Brazil
11.4.5.2 Venezuela
11.4.5.3 Argentina
11.4.5.4 Ecuador
11.4.5.5 Peru
11.4.5.6 Colombia
11.4.5.7 Costa Rica
11.4.5.8 Rest of South America
11.5 Peripheral Intervention Drug-Eluting Devices- Europe Segment Research
11.6 Europe Market Research (Market Size -$Million / $Billion)
11.6.1 Segment type Size and Market Size Analysis
11.6.2 Revenue and Trends
11.6.3 Application Revenue and Trends by type of Application
11.6.4 Company Revenue and Product Analysis
11.6.5 Europe Segment Product type and Application Market Size
11.6.5.1 U.K
11.6.5.2 Germany
11.6.5.3 Italy
11.6.5.4 France
11.6.5.5 Netherlands
11.6.5.6 Belgium
11.6.5.7 Denmark
11.6.5.8 Spain
11.6.5.9 Rest of Europe
11.7 Peripheral Intervention Drug-Eluting Devices - APAC Segment Research
11.8 APAC Market Research (Market Size -$Million / $Billion)
11.8.1 Segment type Size and Market Size Analysis
11.8.2 Revenue and Trends
11.8.3 Application Revenue and Trends by type of Application
11.8.4 Company Revenue and Product Analysis
11.8.5 APAC Segment - Product type and Application Market Size
11.8.5.1 China
11.8.5.2 Australia
11.8.5.3 Japan
11.8.5.4 South Korea
11.8.5.5 India
11.8.5.6 Taiwan
11.8.5.7 Malaysia
11.8.5.8 Hong kong
11.8.5.9 Rest of APAC
11.9 Peripheral Intervention Drug-Eluting Devices - Middle East Segment and Africa Segment Research
11.10 Middle East & Africa Market Research (Market Size -$Million / $Billion)
11.10.1 Segment type Size and Market Size Analysis
11.10.2 Revenue and Trend Analysis
11.10.3 Application Revenue and Trends by type of Application
11.10.4 Company Revenue and Product Analysis
11.10.5 Middle East Segment Product type and Application Market Size
11.10.5.1 Israel
11.10.5.2 Saudi Arabia
11.10.5.3 UAE
11.10.6 Africa Segment Analysis
11.10.6.1 South Africa
11.10.6.2 Rest of Middle East & Africa
12. Peripheral Intervention Drug-Eluting Devices Market - Entropy
12.1 New product launches
12.2 M&A s, collaborations, JVs and partnerships
13. Peripheral Intervention Drug-Eluting Devices Market - Industry / Segment Competition landscape Premium
13.1 Market Share Analysis
13.1.1 Market Share by Country- Top companies
13.1.2 Market Share by Region- Top 10 companies
13.1.3 Market Share by type of Application - Top 10 companies
13.1.4 Market Share by type of Product / Product category- Top 10 companies
13.1.5 Market Share at global level - Top 10 companies
13.1.6 Best Practises for companies
14. Peripheral Intervention Drug-Eluting Devices Market - Key Company List by Country Premium
15. Peripheral Intervention Drug-Eluting Devices Market Company Analysis
15.1 Market Share, Company Revenue, Products, M&A, Developments
15.2 Abbott Laboratory
15.3 B. Braun Melsungen Ag
15.4 Biosensors International Group Ltd
15.5 Boston Scientific Corporation
15.6 C R Bard, Inc
15.7 Cardinal Health
15.8 Medtronic Plc
15.9 St Jude Medical, Inc
15.10 Terumo Corporation
15.11 The Lubrizol Corporation
15.12 Company 11
15.13 Company 12 & More
*Financials would be provided on a best efforts basis for private companies
16. Peripheral Intervention Drug-Eluting Devices Market - Appendix16.1 Abbreviations
16.2 Sources
17. Peripheral Intervention Drug-Eluting Devices Market - Methodology
17.1 Research Methodology
17.1.1 Company Expert Interviews
17.1.2 Industry Databases
17.1.3 Associations
17.1.4 Company News
17.1.5 Company Annual Reports
17.1.6 Application Trends
17.1.7 New Products and Product database
17.1.8 Company Transcripts
17.1.9 R&D Trends
17.1.10 Key Opinion Leaders Interviews
17.1.11 Supply and Demand Trends
LIST OF TABLES
1.Global Global Peripheral Intervention Drug-Eluting Device Market, By Procedure Market 2023-2030 ($M)1.1 Plain Old Balloon Angioplasty Market 2023-2030 ($M) - Global Industry Research
1.2 Percutaneous Transluminal Angioplasty Market 2023-2030 ($M) - Global Industry Research
2.Global Global Peripheral Intervention Drug-Eluting Device Market, By Type Market 2023-2030 ($M)
2.1 Drug-Eluting Balloon Market 2023-2030 ($M) - Global Industry Research
2.2 Drug-Eluting Stent Market 2023-2030 ($M) - Global Industry Research
3.Global Global Peripheral Intervention Drug-Eluting Device Market, By Procedure Market 2023-2030 (Volume/Units)
3.1 Plain Old Balloon Angioplasty Market 2023-2030 (Volume/Units) - Global Industry Research
3.2 Percutaneous Transluminal Angioplasty Market 2023-2030 (Volume/Units) - Global Industry Research
4.Global Global Peripheral Intervention Drug-Eluting Device Market, By Type Market 2023-2030 (Volume/Units)
4.1 Drug-Eluting Balloon Market 2023-2030 (Volume/Units) - Global Industry Research
4.2 Drug-Eluting Stent Market 2023-2030 (Volume/Units) - Global Industry Research
5.North America Global Peripheral Intervention Drug-Eluting Device Market, By Procedure Market 2023-2030 ($M)
5.1 Plain Old Balloon Angioplasty Market 2023-2030 ($M) - Regional Industry Research
5.2 Percutaneous Transluminal Angioplasty Market 2023-2030 ($M) - Regional Industry Research
6.North America Global Peripheral Intervention Drug-Eluting Device Market, By Type Market 2023-2030 ($M)
6.1 Drug-Eluting Balloon Market 2023-2030 ($M) - Regional Industry Research
6.2 Drug-Eluting Stent Market 2023-2030 ($M) - Regional Industry Research
7.South America Global Peripheral Intervention Drug-Eluting Device Market, By Procedure Market 2023-2030 ($M)
7.1 Plain Old Balloon Angioplasty Market 2023-2030 ($M) - Regional Industry Research
7.2 Percutaneous Transluminal Angioplasty Market 2023-2030 ($M) - Regional Industry Research
8.South America Global Peripheral Intervention Drug-Eluting Device Market, By Type Market 2023-2030 ($M)
8.1 Drug-Eluting Balloon Market 2023-2030 ($M) - Regional Industry Research
8.2 Drug-Eluting Stent Market 2023-2030 ($M) - Regional Industry Research
9.Europe Global Peripheral Intervention Drug-Eluting Device Market, By Procedure Market 2023-2030 ($M)
9.1 Plain Old Balloon Angioplasty Market 2023-2030 ($M) - Regional Industry Research
9.2 Percutaneous Transluminal Angioplasty Market 2023-2030 ($M) - Regional Industry Research
10.Europe Global Peripheral Intervention Drug-Eluting Device Market, By Type Market 2023-2030 ($M)
10.1 Drug-Eluting Balloon Market 2023-2030 ($M) - Regional Industry Research
10.2 Drug-Eluting Stent Market 2023-2030 ($M) - Regional Industry Research
11.APAC Global Peripheral Intervention Drug-Eluting Device Market, By Procedure Market 2023-2030 ($M)
11.1 Plain Old Balloon Angioplasty Market 2023-2030 ($M) - Regional Industry Research
11.2 Percutaneous Transluminal Angioplasty Market 2023-2030 ($M) - Regional Industry Research
12.APAC Global Peripheral Intervention Drug-Eluting Device Market, By Type Market 2023-2030 ($M)
12.1 Drug-Eluting Balloon Market 2023-2030 ($M) - Regional Industry Research
12.2 Drug-Eluting Stent Market 2023-2030 ($M) - Regional Industry Research
13.MENA Global Peripheral Intervention Drug-Eluting Device Market, By Procedure Market 2023-2030 ($M)
13.1 Plain Old Balloon Angioplasty Market 2023-2030 ($M) - Regional Industry Research
13.2 Percutaneous Transluminal Angioplasty Market 2023-2030 ($M) - Regional Industry Research
14.MENA Global Peripheral Intervention Drug-Eluting Device Market, By Type Market 2023-2030 ($M)
14.1 Drug-Eluting Balloon Market 2023-2030 ($M) - Regional Industry Research
14.2 Drug-Eluting Stent Market 2023-2030 ($M) - Regional Industry Research
LIST OF FIGURES
1.US Peripheral Intervention Drug-Eluting Devices Market Revenue, 2023-2030 ($M)2.Canada Peripheral Intervention Drug-Eluting Devices Market Revenue, 2023-2030 ($M)
3.Mexico Peripheral Intervention Drug-Eluting Devices Market Revenue, 2023-2030 ($M)
4.Brazil Peripheral Intervention Drug-Eluting Devices Market Revenue, 2023-2030 ($M)
5.Argentina Peripheral Intervention Drug-Eluting Devices Market Revenue, 2023-2030 ($M)
6.Peru Peripheral Intervention Drug-Eluting Devices Market Revenue, 2023-2030 ($M)
7.Colombia Peripheral Intervention Drug-Eluting Devices Market Revenue, 2023-2030 ($M)
8.Chile Peripheral Intervention Drug-Eluting Devices Market Revenue, 2023-2030 ($M)
9.Rest of South America Peripheral Intervention Drug-Eluting Devices Market Revenue, 2023-2030 ($M)
10.UK Peripheral Intervention Drug-Eluting Devices Market Revenue, 2023-2030 ($M)
11.Germany Peripheral Intervention Drug-Eluting Devices Market Revenue, 2023-2030 ($M)
12.France Peripheral Intervention Drug-Eluting Devices Market Revenue, 2023-2030 ($M)
13.Italy Peripheral Intervention Drug-Eluting Devices Market Revenue, 2023-2030 ($M)
14.Spain Peripheral Intervention Drug-Eluting Devices Market Revenue, 2023-2030 ($M)
15.Rest of Europe Peripheral Intervention Drug-Eluting Devices Market Revenue, 2023-2030 ($M)
16.China Peripheral Intervention Drug-Eluting Devices Market Revenue, 2023-2030 ($M)
17.India Peripheral Intervention Drug-Eluting Devices Market Revenue, 2023-2030 ($M)
18.Japan Peripheral Intervention Drug-Eluting Devices Market Revenue, 2023-2030 ($M)
19.South Korea Peripheral Intervention Drug-Eluting Devices Market Revenue, 2023-2030 ($M)
20.South Africa Peripheral Intervention Drug-Eluting Devices Market Revenue, 2023-2030 ($M)
21.North America Peripheral Intervention Drug-Eluting Devices By Application
22.South America Peripheral Intervention Drug-Eluting Devices By Application
23.Europe Peripheral Intervention Drug-Eluting Devices By Application
24.APAC Peripheral Intervention Drug-Eluting Devices By Application
25.MENA Peripheral Intervention Drug-Eluting Devices By Application
26.Medtronic Plc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
27.Boston Scientific Corporation, Sales /Revenue, 2015-2018 ($Mn/$Bn)
28.Abbott Laboratory, Sales /Revenue, 2015-2018 ($Mn/$Bn)
29.Cardinal Health, Sales /Revenue, 2015-2018 ($Mn/$Bn)
30.B. Braun Melsungen Ag, Sales /Revenue, 2015-2018 ($Mn/$Bn)
31.Biosensors International Group Ltd, Sales /Revenue, 2015-2018 ($Mn/$Bn)
32.C R Bard, Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
33.St Jude Medical, Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
34.The Lubrizol Corporation, Sales /Revenue, 2015-2018 ($Mn/$Bn)
35.Terumo Corporation, Sales /Revenue, 2015-2018 ($Mn/$Bn)